NIDA award supports Ensysce's development of opioid overdose protection platform Sep. 19, 2018 No Comments
Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02 Aug. 27, 2018 No Comments
Omeros obtains approvals to begin phase I trial with PDE7 inhibitor OMS-527 June 28, 2018 No Comments
DSMB of Aladote phase Ib/IIa study to treat paracetamol poisoning finds no safety concerns June 25, 2018 No Comments